Yuto Terashima
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prognostic impact of thyroid transcription factor-1 expression and the efficacy of carboplatin plus (nab-) paclitaxel in non-squamous non-small cell lung cancer complicated with idiopathic interstitial pneumonias.
Journal: Translational lung cancer research
Published: November 28, 2025
Retrospective study on the tolerability using a four-cycle completion in elderly patients with extensive-stage small-cell lung cancer: a body mass index-based analysis.
Journal: Translational lung cancer research
Published: September 12, 2025
Corrigendum to 'Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC' [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659].
Journal: JTO clinical and research reports
Published: January 06, 2025
IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report.
Journal: Frontiers in immunology
Published: January 15, 2024
Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC.
Journal: JTO clinical and research reports
Published: November 09, 2023
Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC.
Journal: JTO clinical and research reports
Published: July 03, 2023
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy.
Journal: International journal of clinical oncology
Published: June 14, 2023
Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report.
Journal: Thoracic cancer
Published: August 31, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026